m law group advises QureInvest in financing round of Transimmune AG
28.06.2012
QureInvest is a company investing equity in biotech and life science business with a focus on seed and early stage companies.
Transimmune AG is a biotechnology company focusing on research, development, manufacturing, commercialization and marketing of therapeutic solutions based on immune cell modulation.
Counsel QureInvest:
m law group: Dr. Hubert Besner, Axel Heltzel, Dr. Florian Anselm, Dr. Igor Barabash, Kathrin Brügger
Author:
Dr. Hubert Besner
Practice Area:
Start-up & Venture Capital
Industry:
Life Science & Biotech
